Antonio Verdejo-Garcia1, Luke Clark2, Juan Verdejo-Román2, Natalia Albein-Urios2, José M Martinez-Gonzalez2, Blanca Gutierrez2, Carles Soriano-Mas2. 1. Antonio Verdejo-Garcia, PhD, School of Psychology and Psychiatry, Monash University, Melbourne, Australia, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain and Red de Trastornos Adictivos, Universidad de Granada. Granada, Spain; Luke Clark, PhD, Department of Psychology, Centre for Gambling Research at UBC, University of British Columbia, Canada; Juan Verdejo-Román, MSc, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain; Natalia Albein-Urios, PhD, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain; José M. Martinez-Gonzalez, PhD, Red de Trastornos Adictivos, Universidad de Granada, Granada, Spain and Centro Provincial de Drogodependencias, Diputacion de Granada, Granada, Spain; Blanca Gutierrez, PhD, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain, Department of Psychiatry, Universidad de Granada, Granada, Spain and CIBERSAM, Carlos III Health Institute, Barcelona, Spain; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain and CIBERSAM, Carlos III Health Institute, Barcelona, Spain, Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Spain Antonio.Verdejo@monash.edu. 2. Antonio Verdejo-Garcia, PhD, School of Psychology and Psychiatry, Monash University, Melbourne, Australia, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain and Red de Trastornos Adictivos, Universidad de Granada. Granada, Spain; Luke Clark, PhD, Department of Psychology, Centre for Gambling Research at UBC, University of British Columbia, Canada; Juan Verdejo-Román, MSc, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain; Natalia Albein-Urios, PhD, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain; José M. Martinez-Gonzalez, PhD, Red de Trastornos Adictivos, Universidad de Granada, Granada, Spain and Centro Provincial de Drogodependencias, Diputacion de Granada, Granada, Spain; Blanca Gutierrez, PhD, Institute of Neuroscience F. Oloriz, Universidad de Granada, Granada, Spain, Department of Psychiatry, Universidad de Granada, Granada, Spain and CIBERSAM, Carlos III Health Institute, Barcelona, Spain; Carles Soriano-Mas, PhD, Department of Psychiatry, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain and CIBERSAM, Carlos III Health Institute, Barcelona, Spain, Department of Psychobiology and Methodology of Health Sciences, Universitat Autònoma de Barcelona, Spain.
Authors: J F Navas; A Barrós-Loscertales; V Costumero-Ramos; J Verdejo-Román; R Vilar-López; A Verdejo-García Journal: Int J Obes (Lond) Date: 2017-08-18 Impact factor: 5.095
Authors: Kyle L Ploense; Philip Vieira; Lana Bubalo; Gema Olivarria; Amanda E Carr; Karen K Szumlinski; Tod E Kippin Journal: Psychopharmacology (Berl) Date: 2017-12-12 Impact factor: 4.530